美国胃癌一级与二级预防策略:共识声明
2020年斯坦福大学峰会汇集研究者、政策制定者、资助方与倡导者,通过结构化文献综述评估胃癌一级和二级预防方法的有效性、潜在获益与危害。共识指出,幽门螺杆菌检测与治疗在随机对照试验中可降低胃癌特异性死亡率,内镜筛查在观察性研究中与死亡率下降相关,但多数证据来自美国以外。作者呼吁针对美国高风险移民和少数族裔人群开展预防试验,并就策略应用于异质性美国人群提出建议。
要点
- 幽门螺杆菌检测与治疗在随机对照试验中可降低胃癌特异性死亡率。
- 内镜筛查在观察性研究中与胃癌特异性死亡率下降相关。
- 现有随机对照试验和多数观察性数据来自美国以外,需本土高风险人群试验。
核心结论
- 有大量高质量国际研究数据支持胃癌预防,但亟需针对美国高风险移民和少数族裔人群的癌症预防试验。
研究设计与样本
- 2020年3月5-6日斯坦福大学峰会形成写作组,通过结构化文献综述评估一级和二级预防方法,本文为共识声明。
主要发现
- 美国胃癌负担分布高度不均,不成比例地落在亚裔、非裔、西班牙裔及美洲印第安/阿拉斯加原住民人群。
- 随机对照试验中幽门螺杆菌检测与治疗策略可降低胃癌特异性死亡率。
- 设计良好的观察性和生态学研究中内镜筛查策略与胃癌特异性死亡率降低相关。
- 所有一级预防随机对照试验数据及多数二级预防观察性数据均来自美国以外来源。
临床怎么用
- 作者就一级和二级预防策略如何应用于异质性美国人群提出建议。
局限性
- 所有一级预防随机对照试验数据及多数二级预防观察性数据来自非美国来源。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND & AIMS: Gastric cancer (GC) remains a leading cause of mortality among certain racial, ethnic, and immigrant groups in the United States (US). The majority of GCs are diagnosed at advanced stages, and overall survival remains poor. There exist no structured national strategies for GC prevention in the US. METHODS: On March 5-6, 2020 a summit of researchers, policy makers, public funders, and advocacy leaders was convened at Stanford University to address this critical healthcare disparity. After this summit, a writing group was formed to critically evaluate the effectiveness, potential benefits, and potential harms of methods of primary and secondary prevention through structured literature review. This article represents a consensus statement prepared by the writing group. RESULTS: The burden of GC is highly inequitably distributed in the US and disproportionately falls on Asian, African American, Hispanic, and American Indian/Alaskan Native populations. In randomized controlled trials, strategies of Helicobacter pylori testing and treatment have been demonstrated to reduce GC-specific mortality. In well-conducted observational and ecologic studies, strategies of endoscopic screening have been associated with reduced GC-specific mortality. Notably however, all randomized controlled trial data (for primary prevention) and the majority of observational data (for secondary prevention) are derived from non-US sources. CONCLUSIONS: There exist substantial, high-quality data supporting GC prevention derived from international studies. There is an urgent need for cancer prevention trials focused on high-risk immigrant and minority populations in the US. The authors offer recommendations on how strategies of primary and secondary prevention can be applied to the heterogeneous US population.
引用
- Huang RJ, Epplein M, Hamashima C, et al. An Approach to the Primary and Secondary Prevention of Gastric Cancer in the United States. Clin Gastroenterol Hepatol. 2021. PMID: 34624563. doi:10.1016/j.cgh.2021.09.039
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。